Literature DB >> 26124476

Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.

Stuart G Baker1, Barnett S Kramer2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26124476      PMCID： PMC4525050          DOI： 10.1200/JCO.2014.58.0092

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  19 in total

1.  Therapeutic decision making: a cost-benefit analysis.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

Review 2.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors:  Margaret Sullivan Pepe; Holly Janes; Gary Longton; Wendy Leisenring; Polly Newcomb
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

Review 3.  Assessment of claims of improved prediction beyond the Framingham risk score.

Authors:  Ioanna Tzoulaki; George Liberopoulos; John P A Ioannidis
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

4.  Probability estimation and machine learning--Editorial.

Authors:  Martin Schumacher
Journal:  Biom J       Date:  2014-07       Impact factor: 2.207

Review 5.  Clinical trial designs for predictive marker validation in cancer treatment trials.

Authors:  Daniel J Sargent; Barbara A Conley; Carmen Allegra; Laurence Collette
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

6.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

7.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

8.  How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.

Authors:  Stuart G Baker; Ewoud Schuit; Ewout W Steyerberg; Michael J Pencina; Andrew Vickers; Andew Vickers; Karel G M Moons; Ben W J Mol; Karen S Lindeman
Journal:  Stat Med       Date:  2014-05-13       Impact factor: 2.373

9.  Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.

Authors:  Andrew J Vickers; Angel M Cronin; Elena B Elkin; Mithat Gonen
Journal:  BMC Med Inform Decis Mak       Date:  2008-11-26       Impact factor: 2.796

Review 10.  External validation of multivariable prediction models: a systematic review of methodological conduct and reporting.

Authors:  Gary S Collins; Joris A de Groot; Susan Dutton; Omar Omar; Milensu Shanyinde; Abdelouahid Tajar; Merryn Voysey; Rose Wharton; Ly-Mee Yu; Karel G Moons; Douglas G Altman
Journal:  BMC Med Res Methodol       Date:  2014-03-19       Impact factor: 4.615
View more
  5 in total

1.  Decision Curves and Relative Utility Curves.

Authors:  Stuart G Baker
Journal:  Med Decis Making       Date:  2019-05-20       Impact factor: 2.583

2.  Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.

Authors:  Kathleen F Kerr; Marshall D Brown; Kehao Zhu; Holly Janes
Journal:  J Clin Oncol       Date:  2016-05-31       Impact factor: 44.544

3.  Assessing the Clinical Impact of Risk Models for Opting Out of Treatment.

Authors:  Kathleen F Kerr; Marshall D Brown; Tracey L Marsh; Holly Janes
Journal:  Med Decis Making       Date:  2019-01-16       Impact factor: 2.583

Review 4.  Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.

Authors:  Ben Van Calster; Laure Wynants; Jan F M Verbeek; Jan Y Verbakel; Evangelia Christodoulou; Andrew J Vickers; Monique J Roobol; Ewout W Steyerberg
Journal:  Eur Urol       Date:  2018-09-19       Impact factor: 20.096

5.  A comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeutics.

Authors:  Yi Shen; Xulin Wang; Sheng Zhang; Gang Qin; Yanmei Liu; Yihua Lu; Feng Liang; Xun Zhuang
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.